Does too much sun cause melanoma?July 23, 2008Is sun exposure a major cause of melanoma? We are continuously bombarded with messages about the dangers of too much sun and the increased risk of melanoma (the less common and deadliest form of skin cancer), but are these dangers real, or is staying out of the sun causing us more harm than good? Two experts debate the issue on BMJ.com today.
Sam Shuster, a consultant dermatologist at Norfolk and Norwich University Hospital, says that sun exposure is the major cause of the common forms of skin cancer, which are all virtually benign, but not the rarer, truly malignant melanoma. Shuster says that the common skin cancers develop in pale, sun exposed skin and are less frequent in people who avoid the sun and use protection. In contrast, melanoma is related to ethnicity rather than pigmentation and in 75% of cases occurs on relatively unexposed sites, especially on the feet of Africans. Melanoma occurrence decreases with greater sun exposure and can be increased by sunscreens, while sun bed exposure has a small inconsistent effect. Therefore, he concludes, any causative effect of ultraviolet light on melanoma can only be minimal. There is good evidence that the reported increase in melanoma incidence is an artefact caused by the incorrect classification of benign naevi as malignant melanomas, this, he argues, explains why melanoma mortality has changed little despite the great increase in alleged incidence. He recognises that ultraviolet light causes the common, mainly benign skin cancers and, like smoking, wrinkles the skin. But he says, this is not a good enough reason for a blanket ban and we have to strike a balance with the sun's many other effects on health-from psychological and immunological, to the synthesis of vitamin D essential for bones and apparent protection against many major organ cancers. But Professor Scott Menzies, from the University of Sydney at the Sydney Melanoma Diagnostic Centre, argues that melanoma is far more common on body sites receiving more sun exposure and in people of races who tend to burn rather than tan. According to Menzies, there is considerable evidence that intermittent sun exposure and sunburn are strong independent indicators of the risk of developing melanoma in white populations. He argues that there is a clear association between increasing cases of melanoma and increasing environmental ultraviolet light. Genetic evidence is also supportive, he claims, with the major genes causing melanoma showing ultraviolet light "signature" mutations, while people deficient in repairing ultraviolet light genetic damage have a 1000 times greater risk of developing the disease. He points to data from Australia which shows that cases of melanoma among young adults fell between 1983 and 1996 and this coincided with strong public health messages to use sun protection. When you examine the geographical, sun exposure and genetic evidence together, sun exposure is clearly a major cause of melanoma, he concludes. BMJ-British Medical Journal | |||||||||||||||||||||
|
Related Melanoma News Articles History of nonmelanoma skin cancer is associated with increased risk for subsequent malignancies Individuals with a history of nonmelanoma skin cancer (NMSC) are at increased risk for other cancers, according to a study published in the August 26 online issue of the Journal of the National Cancer Institute. Researchers discover scent of skin cancer According to new research from the Monell Center, odors from skin can be used to identify basal cell carcinoma, the most common form of skin cancer. The findings, presented at the 236th meeting of the American Chemical Society, may open doors to development of new methods to detect basal cell carcinoma and other forms of skin cancer. Fish cancer gene linked to pigment pattern that attracts mates Though skin cancer is deadly to male fish, it also has one perk: The black melanoma splotches arise from attractive natural markings that lure female mates. A new study published in the Proceedings of the National Academy of Sciences this week shows that the melanoma gene can be conserved in swordtail fish because of its beneficial role in sexual selection. Prototype test for predicting clinical outcome for melanoma patients Investigators from the Melbourne Center of the international Ludwig Institute for Cancer Research (LICR) and Pacific Edge Biotchnology Ltd today reported that they have developed a test to predict whether a patient will progress rapidly from Stage III melanoma to metastatic Stage IV cancer and death. NYU researchers demonstrate activity of mebendazole in metastatic melanoma Researchers at the NYU Cancer Institute and the Ronald O. Perelman Department of Dermatology have identified mebendazole, a drug used globally to treat parasitic infections, as a novel investigational agent for the treatment of chemotherapy-resistant malignant melanoma. VCU Massey Cancer Center and VCU Institute of Molecular Medicine Researchers Publish Findings of a New Chemoprevention Gene Therapy That Kills Pancreatic Cancer Cells Researchers at the Virginia Commonwealth University Massey Cancer Center and the VCU Institute of Molecular Medicine have published findings that implicate a new chemoprevention gene therapy (CGT) for preventing and treating pancreatic cancer, one of the most lethal and treatment-resistant forms of cancer. American Cancer Society study finds high use of complementary methods among cancer survivors A new study from researchers at the American Cancer Society finds many cancer patients use complementary and alternative methods, most often prayer, relaxation, supplements, meditation, and massage. New oral angiogenesis inhibitor offers potential nontoxic therapy for a wide range of cancers The first oral, broad-spectrum angiogenesis inhibitor, specially formulated through nanotechnology, shows promising anticancer results in mice, report researchers from Children's Hospital Boston. Inherited melanoma risk: What you do know does help you When people know the results of genetic tests confirming they have inherited an increased risk of developing melanoma, they follow skin cancer screening recommendations more proactively-much like those who have already been diagnosed with the potentially deadly disease. Immune molecule that plays a powerful role in avoiding organ rejection identified When a mouse's immune system is deciding whether to reject a skin graft, one powerful member of a molecular family designed to provoke such a response can effectively reduce the visibility of the mouse's own cells and help the graft survive, researchers say. More Melanoma News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||